Influenza Burden Assessment in the United Kingdom, 1996-2008
NCT01520935 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2012-09-10
Summary
The study will assess the burden of influenza by age, risk status, vaccination status and influenza subtype, in order to create a complete profile of the burden of influenza-related morbidity and mortality in United Kingdom from 1996 to 2008.
Conditions
Interventions
- OTHER
-
Data collection
The study, will use four primary data sources: the General Practice Research Database (GPRD, for mild outcomes), the Hospital Episode Statistics database (HES, for hospitalizations), the Office of National Statistics mortality database (ONS, for mortality), and weekly virology data from the Health Protection Agency (HPA). Weekly time series of the rates of various influenza-related health outcomes in the various databases, such as office visits for acute otitis media and hospitalizations for pneumonia will be constructed. Statistical models, guided by weekly numbers of cases of laboratory-confirmed influenza and respiratory syncytial virus (RSV) contained in the HPA virology data, to estimate the portions of the various outcomes that can be attributed to influenza will be constructed. Finally, the seasonal impact of influenza by risk status, vaccination status, and seasons in which a well-matched versus mismatched influenza vaccine was used, will be assessed.
Sponsors & Collaborators
-
Sage Analytica
collaborator INDUSTRY - lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-09-30
- Primary Completion
- 2012-05-31
- Completion
- 2012-05-31
More Related Trials
-
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine for the Elderly
NCT00938392 ·Status: COMPLETED ·Phase: PHASE3
-
Prophylactic Efficacy of Relenza Against Influenza A and B
NCT01156701 ·Status: COMPLETED
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older
NCT00342940 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older
NCT00329966 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity of a Surface Antigen, Inactivated Influenza Vaccine Formulation 2007-2008
NCT00518453 ·Status: COMPLETED ·Phase: PHASE2
-
Influenza Vaccination Among the Elderly Individuals
NCT02362919 ·Status: COMPLETED
-
Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009, When Administered to Non-Elderly Adult and Elderly Subjects
NCT00748150 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households
NCT00425893 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2009/2010 Recommended in Northern Hemisphere in Non-elderly Adult and in Elderly Subjects
NCT00918268 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective Epidemiological Cohort Study Evaluating Occurrences of Influenza-like Illness.
NCT05184387 ·Status: COMPLETED
-
Post-authorisation Safety Study (PASS) of Influenza Vaccine in United Kingdom (UK)
NCT02567721 ·Status: COMPLETED
-
Phase 1b Influenza Vaccine Study in Healthy Subjects
NCT01181336 ·Status: COMPLETED ·Phase: PHASE1
-
Text Messaging Reminders for Influenza Vaccine in Primary Care
NCT01892631 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge
NCT02071329 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Heterosubtypic Immune Responses to Influenza in Older People
NCT00798343 ·Status: COMPLETED ·Phase: PHASE1
-
Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England
NCT03278067 ·Status: COMPLETED
-
Evaluation of Influenza-Specific Immune Responses in Children and Adults During the 2010-2011 Influenza Season in the U.S.
NCT01262079 ·Status: COMPLETED
-
Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?
NCT01001325 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2 Study of Immunogenicity, Safety and Tolerability of CSL412 in Elderly Participants
NCT00479648 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults
NCT00989287 ·Status: COMPLETED ·Phase: PHASE3
-
Support Annual Strain Update, Safety and Immunogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases.
NCT00522067 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects
NCT00630331 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Immunogenicity and Safety of the 2007-2008 Influenza Vaccine
NCT00491257 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2008-2009 Formulation
NCT00718146 ·Status: COMPLETED ·Phase: PHASE2
-
Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)
NCT04664075 ·Status: TERMINATED